Latest Kaiser Health News Stories
Índice de masa corporal: una medida errónea del peso que afecta el tratamiento de la obesidad
Los tratamientos actuales para la obesidad y los trastornos alimentarios, y sus costos, muchas veces se basan en esta medida que no está amparada en la ciencia.
Votantes, más motivados para ir a las urnas tras prohibición del aborto, revela encuesta
El sondeo también mostró que la mayoría de los votantes, ya sean demócratas o republicanos, no cree que el aborto deba prohibirse en casos de violación o incesto, ni apoyan las leyes que establecen condenas para los proveedores de abortos y las mujeres que abortan.
Abortion Bans Are Motivating Midterm Voters, Poll Shows
A new KFF poll shows Democrats and those living in states where abortion is illegal say the issue has made them more motivated to vote. It also shows that 70% of Republicans oppose total abortion bans.
BMI: The Mismeasure of Weight and the Mistreatment of Obesity
The human body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
KHN’s ‘What the Health?’: Looking Ahead to the Lame-Duck Session
Congress won’t be back in Washington until after Election Day, but lawmakers have left themselves a long list of items to finish up in November and December, including unfinished health care policies. Sandhya Raman of CQ Roll Call; Jessie Hellmann, also of CQ Roll Call; and Mary Agnes Carey of KHN join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews KHN’s Sam Whitehead, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a family who tried to use urgent care to save money, but ended up with a big emergency room bill anyway.
Nursing Home Surprise: Advantage Plans May Shorten Stays to Less Time Than Medicare Covers
Private Medicare Advantage health plans are increasingly ending coverage for skilled nursing or rehab services before medical providers think patients are healthy enough to go home, doctors and patient advocates say.
Journalists Dig In on the Fiscal Health of the Nation and Hospital Closures in Rural Missouri
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
KHN’s ‘What the Health?’: On Government Spending, Congress Decides Not to Decide
Congress has once again decided not to decide how to fund the federal government in time for the start of the fiscal year, racing toward a midnight Sept. 30 deadline to pass a stopgap bill that would keep the lights on for two more months. However, it does appear the FDA’s program that gets drugmakers to help fund some of the agency’s review staff will be renewed in time to stop pink slips from being sent. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Victoria Knight of Axios join KHN’s Julie Rovner to discuss these topics and more. Also this week, Rovner interviews filmmaker Cynthia Lowen, whose new documentary, “Battleground,” explores how anti-abortion forces played the long game to overturn Roe v. Wade.
Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims
Massachusetts is the latest state to settle with St. Louis-based Centene Corp. over allegations that it overcharged Medicaid prescription drug programs.
KHN’s ‘What the Health?’: Biden Declares the Pandemic ‘Over’
President Joe Biden, in an interview with CBS’ “60 Minutes,” declared the covid-19 pandemic “over,” stoking confusion for members of his administration trying to persuade Congress to provide more funding to fight the virus and the public to get the latest boosters. Meanwhile, concerns about a return of medical inflation is helping boost insurance premiums even as private companies race to get their piece of the health pie. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Lauren Weber of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories they think you should read, too.
Padres con hijos muy enfermos encuentran consuelo y esperanza en la ayuda de hospicio en el hogar
Si bien el cáncer es una de las principales enfermedades que afectan a los niños en cuidados paliativos, muchos otros tienen defectos congénitos raros, deficiencias neurológicas graves o deficiencias metabólicas poco comunes.
Shift in Child Hospice Care Is a Lifeline for Parents Seeking a Measure of Comfort and Hope
Terminally ill children, unlike adults, can get hospice services while continuing to receive life-extending or curative care. More than a decade after the inception of the federal policy, it is widely credited with improving the quality of life for ailing children and their families, even as some parents find themselves in a painful stasis.
While Inflation Takes a Toll on Seniors, Billions of Dollars in Benefits Go Unused
With prices of necessities rising dramatically, many older Americans are having trouble making ends meet. They often don’t know that help is available from a variety of programs, and some sources of financial assistance are underused.
‘An Arm and a Leg’: The New Cap on Medicare Drug Costs
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
‘It’s Becoming Too Expensive to Live’: Anxious Older Adults Try to Cope With Limited Budgets
Three women explain how life’s surprises can catapult their efforts to carefully manage limited budgets and lead to financial distress.
Journalists Dig Into Questions About the 988 Hotline and Inflation Reduction Act
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
KHN’s ‘What the Health?’: Wrapping Up Summer’s Health News
President Joe Biden has signed the Inflation Reduction Act and Congress is gone until after Labor Day. But the administration and lawmakers left lots of health policy achievements behind, including new rules to facilitate the sale of over-the-counter hearing aids and a potential reorganization of the Centers for Disease Control and Prevention. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
Inflation Reduction Act Contains Important Cost-Saving Changes for Many Patients — Maybe for You
The legislation, which the House is expected to pass Friday, would allow the federal government, for the first time, to negotiate the price of some drugs that Medicare buys. It also would extend the enhanced subsidies for people who buy insurance on the Affordable Care Act marketplaces.
KHN’s ‘What the Health?’: A Big Week for Biden
Congress is leaving for its annual summer break having accomplished far more than many expected, including, barring unforeseen snags, a bill to address the cost of prescription drugs for Medicare beneficiaries and extend the enhanced subsidies for insurance premiums under the Affordable Care Act. Meanwhile, the abortion issue continues to roil the nation as Indiana becomes the first state to ban the procedure in almost all cases since the Supreme Court overruled the constitutional right to abortion in June. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
No, the Senate-Passed Reconciliation Bill Won’t Strip $300 Billion From Medicare
Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldn’t result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.
